Captrust Financial Advisors Recursion Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.09 - $10.79 $32,611 - $69,131
6,407 Added 1.55%
419,721 $4.14 Million
Q3 2023

Nov 14, 2023
BUY
$6.59 - $15.86 $2.72 Million - $6.56 Million
413,314 New
413,314 $3.16 Million
Q1 2022

May 16, 2022
BUY
$6.16 - $18.03 $868 - $2,542
141 Added 705.0%
161 $1,000
Q4 2021

Feb 14, 2022
BUY
$16.14 - $21.86 $322 - $437
20 New
20 $0

Others Institutions Holding RXRX

# of Institutions
289
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.18B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email